The global pancreatic cancer diagnostic market size is expected to reach USD 3.90 billion by 2030. Furthermore, the industry is expected to expand at a CAGR of 6.53% over the forecast period. The introduction of innovative products, coupled with the rising need for early disease diagnosis and increasing research activities to develop advanced diagnostic solutions, is anticipated to drive the global market. ![Global Pancreatic Cancer Diagnostic Market]( "Global Pancreatic Cancer Diagnostic Market")
For instance, in August 2021, Immunovia, Inc. received approval from the Massachusetts Department of Public Health to start testing patients for pancreatic cancer, using the IMMray PanCan-d test. It is a laboratory-developed test for the early detection of pancreatic cancer. The market is projected to witness lucrative growth opportunities owing to increased research funding, technological advancements in diagnostic tests, and rising efforts from manufacturers to develop precise testing solutions. For instance, in December 2022, Bluestar Genomics, Inc. announced the initiation of one of the largest clinical trials for the early detection of pancreatic cancer.
In addition, the growing demand for developing novel automated and accurate diagnostic solutions to reduce the disease burden worldwide has gained momentum in recent years. Research related to novel biomarker identification, nanoparticle utilization for pancreatic cancer, and the introduction of artificial intelligence (AI) in diagnosis processes are factors projected to fuel the growth. In addition, the incorporation of AI in imaging pathology and biomarkers tests will boost the adoption of diagnostic tests for detecting pancreatic cancer.
For instance, in April 2022, Fujitsu collaborated with Southern Tohoku General Hospital in Fukushima, Japan to develop AI solutions that detect pancreatic malignancy from CT scans at an early stage. Rising investments by key market players in the production of effective and advanced diagnostic tools and various strategic initiatives undertaken by them are likely to create new avenues for market expansion. For instance, in March 2023, Prestige Biopharma Limited developed a first-in-class diagnostic kit for detecting pancreatic cancer. The test helps diagnose the disease at an early stage to improve treatment outcomes and survival rates globally.
Similarly, a favorable regulatory framework for diagnostic tools is another factor supporting market expansion. For instance, in January 2023, the U. S. FDA granted a breakthrough device designation to the OverC Multi-Cancer Detection Blood Test (MCDBT) for the early diagnosis of various forms of cancers, including lung, liver, esophageal, and pancreatic cancer in adults with average and intermediate risk.
For instance, in August 2021, Immunovia, Inc. received approval from the Massachusetts Department of Public Health to start testing patients for pancreatic cancer, using the IMMray PanCan-d test. It is a laboratory-developed test for the early detection of pancreatic cancer. The market is projected to witness lucrative growth opportunities owing to increased research funding, technological advancements in diagnostic tests, and rising efforts from manufacturers to develop precise testing solutions. For instance, in December 2022, Bluestar Genomics, Inc. announced the initiation of one of the largest clinical trials for the early detection of pancreatic cancer.
In addition, the growing demand for developing novel automated and accurate diagnostic solutions to reduce the disease burden worldwide has gained momentum in recent years. Research related to novel biomarker identification, nanoparticle utilization for pancreatic cancer, and the introduction of artificial intelligence (AI) in diagnosis processes are factors projected to fuel the growth. In addition, the incorporation of AI in imaging pathology and biomarkers tests will boost the adoption of diagnostic tests for detecting pancreatic cancer.
For instance, in April 2022, Fujitsu collaborated with Southern Tohoku General Hospital in Fukushima, Japan to develop AI solutions that detect pancreatic malignancy from CT scans at an early stage. Rising investments by key market players in the production of effective and advanced diagnostic tools and various strategic initiatives undertaken by them are likely to create new avenues for market expansion. For instance, in March 2023, Prestige Biopharma Limited developed a first-in-class diagnostic kit for detecting pancreatic cancer. The test helps diagnose the disease at an early stage to improve treatment outcomes and survival rates globally.
Similarly, a favorable regulatory framework for diagnostic tools is another factor supporting market expansion. For instance, in January 2023, the U. S. FDA granted a breakthrough device designation to the OverC Multi-Cancer Detection Blood Test (MCDBT) for the early diagnosis of various forms of cancers, including lung, liver, esophageal, and pancreatic cancer in adults with average and intermediate risk.
Pancreatic Cancer Diagnostic Market Report Highlights
- The consumables segment held the largest revenue share in 2022, owing to the rising adoption of consumables in diagnostic procedures, increased R&D investments, and growing instances of launches of technologically advanced diagnostic kits and reagents
- The imaging test segment accounted for the largest market revenue share in 2022 due to its ability to allow healthcare professionals to detect and diagnose pancreatic cancer at earlier stages and the high preference for imaging modules to position tumors
- Based on end-use, the hospital segment dominated the market in 2022, whereas the laboratories segment is projected to be the fastest-growing segment over the forecast period
- Asia Pacific is projected to exhibit the fastest growth over the forecast period due to the high unmet needs of the patient population and the increasing investment of key market players in the region
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Test Segment
1.1.1.2 Service Provider Segment
1.1.1.3 Application Segment
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations
1.1.1 Segment Definitions
1.1.1.1 Test Segment
1.1.1.2 Service Provider Segment
1.1.1.3 Application Segment
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Pancreatic Cancer Diagnostic Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Increasing prevalence of pancreatic cancer
3.2.1.2 Growing demand for advanced diagnostic solutions
3.2.2 Market restraint analysis
3.2.2.1 High cost of diagnostic tests and stringent regulatory framework
3.3 Market Analysis Tools
3.3.1 Industry analysis - Porter’s Five Forces
3.3.2 PESTLE analysis
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Increasing prevalence of pancreatic cancer
3.2.1.2 Growing demand for advanced diagnostic solutions
3.2.2 Market restraint analysis
3.2.2.1 High cost of diagnostic tests and stringent regulatory framework
3.3 Market Analysis Tools
3.3.1 Industry analysis - Porter’s Five Forces
3.3.2 PESTLE analysis
Chapter 4 Pancreatic Cancer Diagnostic Market Segment Analysis, By Product, 2018 - 2030 (USD Million)
4.1 Definition and Scope
4.2 Product Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Global Pancreatic Cancer Diagnostic Market, by Product, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Instruments
4.5.1.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2 Consumables
4.5.2.1 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
4.5.3 Services
4.5.3.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
4.2 Product Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Global Pancreatic Cancer Diagnostic Market, by Product, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Instruments
4.5.1.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2 Consumables
4.5.2.1 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
4.5.3 Services
4.5.3.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5 Pancreatic Cancer Diagnostic Market Segment Analysis, By Test Type 2018 - 2030 (USD Million)
5.1 Definition and Scope
5.2 Test Type Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global Pancreatic Cancer Diagnostic Market, by Test Type, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Imaging Test
5.5.1.1 Imaging test market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.2 CT Scan
5.5.1.2.1 CT scan market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.3 MRI
5.5.1.3.1 MRI market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.4 Ultrasound
5.5.1.4.1 Ultrasound market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.5 PET
5.5.1.5.1 PET market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.6 Others
5.5.1.6.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2 Biopsy
5.5.2.1 Biopsy market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3 Blood Test
5.5.3.1 Blood test market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3.2 Liver Function Tests
5.5.3.2.1 Liver function tests market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3.3 Tumor Markers
5.5.3.3.1 Tumor markers market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3.4 Others
5.5.3.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4 Others
5.5.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
5.2 Test Type Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global Pancreatic Cancer Diagnostic Market, by Test Type, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Imaging Test
5.5.1.1 Imaging test market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.2 CT Scan
5.5.1.2.1 CT scan market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.3 MRI
5.5.1.3.1 MRI market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.4 Ultrasound
5.5.1.4.1 Ultrasound market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.5 PET
5.5.1.5.1 PET market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.6 Others
5.5.1.6.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2 Biopsy
5.5.2.1 Biopsy market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3 Blood Test
5.5.3.1 Blood test market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3.2 Liver Function Tests
5.5.3.2.1 Liver function tests market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3.3 Tumor Markers
5.5.3.3.1 Tumor markers market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3.4 Others
5.5.3.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4 Others
5.5.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6 Pancreatic Cancer Diagnostic Market Segment Analysis, By Cancer Type, 2018 - 2030 (USD Million)
6.1 Definition and Scope
6.2 Cancer Type Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global Pancreatic Cancer Diagnostic Market, by Cancer Type, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Exocrine
6.5.1.1 Exocrine cancer market estimates and forecast, 2018 - 2030 (USD Million)
6.5.1.2 Adenocarcinoma
6.5.1.2.1 Adenocarcinoma market estimates and forecast, 2018 - 2030 (USD Million)
6.5.1.3 Squamous Cell Carcinoma
6.5.1.3.1 Squamous cell carcinoma market estimates and forecast, 2018 - 2030 (USD Million)
6.5.1.4 Adenosquamous Carcinoma
6.5.1.4.1 Adenosquamous carcinoma market estimates and forecast, 2018 - 2030 (USD Million)
6.5.1.5 Colloid Carcinoma
6.5.1.5.1 Colloid carcinoma market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2 Endocrine
6.5.2.1 Endocrine cancer market estimates and forecast, 2018 - 2030 (USD Million)
6.2 Cancer Type Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global Pancreatic Cancer Diagnostic Market, by Cancer Type, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Exocrine
6.5.1.1 Exocrine cancer market estimates and forecast, 2018 - 2030 (USD Million)
6.5.1.2 Adenocarcinoma
6.5.1.2.1 Adenocarcinoma market estimates and forecast, 2018 - 2030 (USD Million)
6.5.1.3 Squamous Cell Carcinoma
6.5.1.3.1 Squamous cell carcinoma market estimates and forecast, 2018 - 2030 (USD Million)
6.5.1.4 Adenosquamous Carcinoma
6.5.1.4.1 Adenosquamous carcinoma market estimates and forecast, 2018 - 2030 (USD Million)
6.5.1.5 Colloid Carcinoma
6.5.1.5.1 Colloid carcinoma market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2 Endocrine
6.5.2.1 Endocrine cancer market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7 Pancreatic Cancer Diagnostic Market Segment Analysis, By End-use, 2018 - 2030 (USD Million)
7.1 Definition and Scope
7.2 End-use Market Share Analysis, 2022 & 2030
7.3 Segment Dashboard
7.4 Global Pancreatic Cancer Diagnostic Market, by End-use, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Hospitals
7.5.1.1 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2 Clinics
7.5.2.1 Clinics market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3 Laboratories
7.5.3.1 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4 Others
7.5.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
7.2 End-use Market Share Analysis, 2022 & 2030
7.3 Segment Dashboard
7.4 Global Pancreatic Cancer Diagnostic Market, by End-use, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Hospitals
7.5.1.1 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2 Clinics
7.5.2.1 Clinics market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3 Laboratories
7.5.3.1 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4 Others
7.5.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8 Pancreatic Cancer Diagnostic Market Segment Analysis, By Region, 2018 - 2030 (USD Million)
8.1 Definition & Scope
8.2 Regional Market Share Analysis, 2022 & 2030
8.3 Regional Market Dashboard
8.4 Regional Market Snapshot
8.5 SWOT Analysis
8.5.1 North America
8.5.2 Europe
8.5.3 Asia Pacific
8.5.4 Latin America
8.5.5 Middle East & Africa
8.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
8.6.1 North America
8.6.1.1 North America pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.1.2 U.S.
8.6.1.2.1 Key Country Dynamics
8.6.1.2.2 Competitive Scenario
8.6.1.2.3 Regulatory Framework
8.6.1.2.4 Reimbursement Scenario
8.6.1.2.5 U.S. pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.1.3 Canada
8.6.1.3.1 Key Country Dynamics
8.6.1.3.2 Competitive Scenario
8.6.1.3.3 Regulatory Framework
8.6.1.3.4 Reimbursement Scenario
8.6.1.3.5 Canada pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2 Europe
8.6.2.1 Europe pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.2 UK
8.6.2.2.1 Key Country Dynamics
8.6.2.2.2 Competitive Scenario
8.6.2.2.3 Regulatory Framework
8.6.2.2.4 Reimbursement Scenario
8.6.2.2.5 UK pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.3 Germany
8.6.2.3.1 Key Country Dynamics
8.6.2.3.2 Competitive Scenario
8.6.2.3.3 Regulatory Framework
8.6.2.3.4 Reimbursement Scenario
8.6.2.3.5 Germany pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.4 Spain
8.6.2.4.1 Key Country Dynamics
8.6.2.4.2 Competitive Scenario
8.6.2.4.3 Regulatory Framework
8.6.2.4.4 Reimbursement Scenario
8.6.2.4.5 Spain pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.5 France
8.6.2.5.1 Key Country Dynamics
8.6.2.5.2 Competitive Scenario
8.6.2.5.3 Regulatory Framework
8.6.2.5.4 Reimbursement Scenario
8.6.2.5.5 France pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.6 Italy
8.6.2.6.1 Key Country Dynamics
8.6.2.6.2 Competitive Scenario
8.6.2.6.3 Regulatory Framework
8.6.2.6.4 Reimbursement Scenario
8.6.2.6.5 Italy pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.7 Denmark
8.6.2.7.1 Key Country Dynamics
8.6.2.7.2 Competitive Scenario
8.6.2.7.3 Regulatory Framework
8.6.2.7.4 Reimbursement Scenario
8.6.2.7.5 Denmark pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.8 Sweden
8.6.2.8.1 Key Country Dynamics
8.6.2.8.2 Competitive Scenario
8.6.2.8.3 Regulatory Framework
8.6.2.8.4 Reimbursement Scenario
8.6.2.8.5 Sweden pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.9 Norway
8.6.2.9.1 Key Country Dynamics
8.6.2.9.2 Competitive Scenario
8.6.2.9.3 Regulatory Framework
8.6.2.9.4 Reimbursement Scenario
8.6.2.9.5 Norway pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3 Asia Pacific
8.6.3.1 Asia Pacific pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.2 Japan
8.6.3.2.1 Key Country Dynamics
8.6.3.2.2 Competitive Scenario
8.6.3.2.3 Regulatory Framework
8.6.3.2.4 Reimbursement Scenario
8.6.3.2.5 Japan pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.3 China
8.6.3.3.1 Key Country Dynamics
8.6.3.3.2 Competitive Scenario
8.6.3.3.3 Regulatory Framework
8.6.3.3.4 Reimbursement Scenario
8.6.3.3.5 China pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.4 India
8.6.3.4.1 Key Country Dynamics
8.6.3.4.2 Competitive Scenario
8.6.3.4.3 Regulatory Framework
8.6.3.4.4 Reimbursement Scenario
8.6.3.4.5 India pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.5 South Korea
8.6.3.5.1 Key Country Dynamics
8.6.3.5.2 Competitive Scenario
8.6.3.5.3 Regulatory Framework
8.6.3.5.4 Reimbursement Scenario
8.6.3.5.5 South Korea pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.6 Australia
8.6.3.6.1 Key Country Dynamics
8.6.3.6.2 Competitive Scenario
8.6.3.6.3 Regulatory Framework
8.6.3.6.4 Reimbursement Scenario
8.6.3.6.5 Australia pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.7 Thailand
8.6.3.8.1 Key Country Dynamics
8.6.3.8.2 Competitive Scenario
8.6.3.8.3 Regulatory Framework
8.6.3.8.4 Reimbursement Scenario
8.6.3.8.5 Thailand pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.4 Latin America
8.6.4.1 Latin America pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.4.2 Brazil
8.6.4.2.1 Key Country Dynamics
8.6.4.2.2 Competitive Scenario
8.6.4.2.3 Regulatory Framework
8.6.4.2.4 Reimbursement Scenario
8.6.4.2.5 Brazil pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.4.3 Mexico
8.6.4.3.1 Key Country Dynamics
8.6.4.3.2 Competitive Scenario
8.6.4.3.3 Regulatory Framework
8.6.4.3.4 Reimbursement Scenario
8.6.4.3.5 Mexico pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.4.4 Argentina
8.6.4.4.1 Key Country Dynamics
8.6.4.4.2 Competitive Scenario
8.6.4.4.3 Regulatory Framework
8.6.4.4.4 Reimbursement Scenario
8.6.4.4.5 Argentina pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.5 MEA
8.6.5.1 MEA pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.5.2 South Africa
8.6.5.2.1 Key Country Dynamics
8.6.5.2.2 Competitive Scenario
8.6.5.2.3 Regulatory Framework
8.6.5.2.4 Reimbursement Scenario
8.6.5.2.5 South Africa pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.5.3 Saudi Arabia
8.6.5.3.1 Key Country Dynamics
8.6.5.3.2 Competitive Scenario
8.6.5.3.3 Regulatory Framework
8.6.5.3.4 Reimbursement Scenario
8.6.5.3.5 Saudi Arabia pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.5.4 UAE
8.6.5.4.1 Key Country Dynamics
8.6.5.4.2 Competitive Scenario
8.6.5.4.3 Regulatory Framework
8.6.5.4.4 Reimbursement Scenario
8.6.5.4.5 UAE pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.5.5 Kuwait
8.6.5.5.1 Key Country Dynamics
8.6.5.5.2 Competitive Scenario
8.6.5.5.3 Regulatory Framework
8.6.5.5.4 Reimbursement Scenario
8.6.5.5.5 Kuwait pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.2 Regional Market Share Analysis, 2022 & 2030
8.3 Regional Market Dashboard
8.4 Regional Market Snapshot
8.5 SWOT Analysis
8.5.1 North America
8.5.2 Europe
8.5.3 Asia Pacific
8.5.4 Latin America
8.5.5 Middle East & Africa
8.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
8.6.1 North America
8.6.1.1 North America pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.1.2 U.S.
8.6.1.2.1 Key Country Dynamics
8.6.1.2.2 Competitive Scenario
8.6.1.2.3 Regulatory Framework
8.6.1.2.4 Reimbursement Scenario
8.6.1.2.5 U.S. pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.1.3 Canada
8.6.1.3.1 Key Country Dynamics
8.6.1.3.2 Competitive Scenario
8.6.1.3.3 Regulatory Framework
8.6.1.3.4 Reimbursement Scenario
8.6.1.3.5 Canada pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2 Europe
8.6.2.1 Europe pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.2 UK
8.6.2.2.1 Key Country Dynamics
8.6.2.2.2 Competitive Scenario
8.6.2.2.3 Regulatory Framework
8.6.2.2.4 Reimbursement Scenario
8.6.2.2.5 UK pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.3 Germany
8.6.2.3.1 Key Country Dynamics
8.6.2.3.2 Competitive Scenario
8.6.2.3.3 Regulatory Framework
8.6.2.3.4 Reimbursement Scenario
8.6.2.3.5 Germany pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.4 Spain
8.6.2.4.1 Key Country Dynamics
8.6.2.4.2 Competitive Scenario
8.6.2.4.3 Regulatory Framework
8.6.2.4.4 Reimbursement Scenario
8.6.2.4.5 Spain pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.5 France
8.6.2.5.1 Key Country Dynamics
8.6.2.5.2 Competitive Scenario
8.6.2.5.3 Regulatory Framework
8.6.2.5.4 Reimbursement Scenario
8.6.2.5.5 France pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.6 Italy
8.6.2.6.1 Key Country Dynamics
8.6.2.6.2 Competitive Scenario
8.6.2.6.3 Regulatory Framework
8.6.2.6.4 Reimbursement Scenario
8.6.2.6.5 Italy pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.7 Denmark
8.6.2.7.1 Key Country Dynamics
8.6.2.7.2 Competitive Scenario
8.6.2.7.3 Regulatory Framework
8.6.2.7.4 Reimbursement Scenario
8.6.2.7.5 Denmark pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.8 Sweden
8.6.2.8.1 Key Country Dynamics
8.6.2.8.2 Competitive Scenario
8.6.2.8.3 Regulatory Framework
8.6.2.8.4 Reimbursement Scenario
8.6.2.8.5 Sweden pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.9 Norway
8.6.2.9.1 Key Country Dynamics
8.6.2.9.2 Competitive Scenario
8.6.2.9.3 Regulatory Framework
8.6.2.9.4 Reimbursement Scenario
8.6.2.9.5 Norway pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3 Asia Pacific
8.6.3.1 Asia Pacific pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.2 Japan
8.6.3.2.1 Key Country Dynamics
8.6.3.2.2 Competitive Scenario
8.6.3.2.3 Regulatory Framework
8.6.3.2.4 Reimbursement Scenario
8.6.3.2.5 Japan pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.3 China
8.6.3.3.1 Key Country Dynamics
8.6.3.3.2 Competitive Scenario
8.6.3.3.3 Regulatory Framework
8.6.3.3.4 Reimbursement Scenario
8.6.3.3.5 China pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.4 India
8.6.3.4.1 Key Country Dynamics
8.6.3.4.2 Competitive Scenario
8.6.3.4.3 Regulatory Framework
8.6.3.4.4 Reimbursement Scenario
8.6.3.4.5 India pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.5 South Korea
8.6.3.5.1 Key Country Dynamics
8.6.3.5.2 Competitive Scenario
8.6.3.5.3 Regulatory Framework
8.6.3.5.4 Reimbursement Scenario
8.6.3.5.5 South Korea pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.6 Australia
8.6.3.6.1 Key Country Dynamics
8.6.3.6.2 Competitive Scenario
8.6.3.6.3 Regulatory Framework
8.6.3.6.4 Reimbursement Scenario
8.6.3.6.5 Australia pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.7 Thailand
8.6.3.8.1 Key Country Dynamics
8.6.3.8.2 Competitive Scenario
8.6.3.8.3 Regulatory Framework
8.6.3.8.4 Reimbursement Scenario
8.6.3.8.5 Thailand pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.4 Latin America
8.6.4.1 Latin America pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.4.2 Brazil
8.6.4.2.1 Key Country Dynamics
8.6.4.2.2 Competitive Scenario
8.6.4.2.3 Regulatory Framework
8.6.4.2.4 Reimbursement Scenario
8.6.4.2.5 Brazil pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.4.3 Mexico
8.6.4.3.1 Key Country Dynamics
8.6.4.3.2 Competitive Scenario
8.6.4.3.3 Regulatory Framework
8.6.4.3.4 Reimbursement Scenario
8.6.4.3.5 Mexico pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.4.4 Argentina
8.6.4.4.1 Key Country Dynamics
8.6.4.4.2 Competitive Scenario
8.6.4.4.3 Regulatory Framework
8.6.4.4.4 Reimbursement Scenario
8.6.4.4.5 Argentina pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.5 MEA
8.6.5.1 MEA pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.5.2 South Africa
8.6.5.2.1 Key Country Dynamics
8.6.5.2.2 Competitive Scenario
8.6.5.2.3 Regulatory Framework
8.6.5.2.4 Reimbursement Scenario
8.6.5.2.5 South Africa pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.5.3 Saudi Arabia
8.6.5.3.1 Key Country Dynamics
8.6.5.3.2 Competitive Scenario
8.6.5.3.3 Regulatory Framework
8.6.5.3.4 Reimbursement Scenario
8.6.5.3.5 Saudi Arabia pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.5.4 UAE
8.6.5.4.1 Key Country Dynamics
8.6.5.4.2 Competitive Scenario
8.6.5.4.3 Regulatory Framework
8.6.5.4.4 Reimbursement Scenario
8.6.5.4.5 UAE pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
8.6.5.5 Kuwait
8.6.5.5.1 Key Country Dynamics
8.6.5.5.2 Competitive Scenario
8.6.5.5.3 Regulatory Framework
8.6.5.5.4 Reimbursement Scenario
8.6.5.5.5 Kuwait pancreatic cancer diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9 Pancreatic Cancer Diagnostic Market - Competitive Landscape
9.1 Recent Developments & Impact Analysis, by Key Market Participants
9.1.1 Ansoff matrix
9.1.2 Heat map analysis
9.1.3 Major Deals and Strategic Alliances Analysis
9.1.3.1 Joint Ventures
9.1.3.2 Licensing Agreements
9.1.3.3 Product Launches
9.1.3.4 Conferences and Campaigns
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.3 Vendor Landscape
9.3.1 List of key distributors and channel partners
9.3.2 Key customers
9.4 Public Companies
9.4.1 Competitive Dashboard Analysis
9.4.1.1 Market Differentiators
9.5 Private Companies
9.5.1 List of key emerging companies
9.6 Company Profiles
9.6.1 QIAGEN
9.6.1.1 Company overview
9.6.1.2 Financial performance
9.6.1.3 Product benchmarking
9.6.1.4 Strategic Initiatives
9.6.2 Illumina, Inc.
9.6.2.1 Company overview
9.6.2.2 Financial performance
9.6.2.3 Product benchmarking
9.6.2.4 Strategic Initiatives
9.6.3 BD
9.6.3.1 Company overview
9.6.3.2 Financial performance
9.6.3.3 Product benchmarking
9.6.3.4 Strategic Initiatives
9.6.4 Thermo Fisher Scientific, Inc.
9.6.4.1 Company overview
9.6.4.2 Financial performance
9.6.4.3 Product benchmarking
9.6.4.4 Strategic Initiatives
9.6.5 Myriad Genetics, Inc.
9.6.5.1 Company overview
9.6.5.2 Financial performance
9.6.5.3 Product benchmarking
9.6.5.4 Strategic Initiatives
9.6.6 Agilent Technologies, Inc.
9.6.6.1 Company overview
9.6.6.2 Financial performance
9.6.6.3 Product benchmarking
9.6.6.4 Strategic Initiatives
9.6.7 F. Hoffmann-La Roche Ltd.
9.6.7.1 Company overview
9.6.7.2 Financial performance
9.6.7.3 Product benchmarking
9.6.7.4 Strategic initiatives
9.6.8 Hitachi, Ltd
9.6.8.1 Company overview
9.6.8.2 Financial performance
9.6.8.3 Product benchmarking
9.6.8.4 Strategic initiatives
9.6.9 Koninklijke Philips N.V.
9.6.9.1 Company overview
9.6.9.2 Financial performance
9.6.9.3 Product benchmarking
9.6.9.4 Strategic initiatives
9.6.10 Abbott
9.6.10.1 Company overview
9.6.10.2 Financial performance
9.6.10.3 Product benchmarking
9.6.10.4 Strategic initiatives
9.6.11 Danaher
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.11.4 Strategic initiatives
9.6.12 Prestige Biopharma Ltd.
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.11.4 Strategic initiatives
9.6.13 BioMarker Strategies
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.11.4 Strategic initiatives
9.6.14 ASURAGEN, INC
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.11.4 Strategic initiatives
9.1.1 Ansoff matrix
9.1.2 Heat map analysis
9.1.3 Major Deals and Strategic Alliances Analysis
9.1.3.1 Joint Ventures
9.1.3.2 Licensing Agreements
9.1.3.3 Product Launches
9.1.3.4 Conferences and Campaigns
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.3 Vendor Landscape
9.3.1 List of key distributors and channel partners
9.3.2 Key customers
9.4 Public Companies
9.4.1 Competitive Dashboard Analysis
9.4.1.1 Market Differentiators
9.5 Private Companies
9.5.1 List of key emerging companies
9.6 Company Profiles
9.6.1 QIAGEN
9.6.1.1 Company overview
9.6.1.2 Financial performance
9.6.1.3 Product benchmarking
9.6.1.4 Strategic Initiatives
9.6.2 Illumina, Inc.
9.6.2.1 Company overview
9.6.2.2 Financial performance
9.6.2.3 Product benchmarking
9.6.2.4 Strategic Initiatives
9.6.3 BD
9.6.3.1 Company overview
9.6.3.2 Financial performance
9.6.3.3 Product benchmarking
9.6.3.4 Strategic Initiatives
9.6.4 Thermo Fisher Scientific, Inc.
9.6.4.1 Company overview
9.6.4.2 Financial performance
9.6.4.3 Product benchmarking
9.6.4.4 Strategic Initiatives
9.6.5 Myriad Genetics, Inc.
9.6.5.1 Company overview
9.6.5.2 Financial performance
9.6.5.3 Product benchmarking
9.6.5.4 Strategic Initiatives
9.6.6 Agilent Technologies, Inc.
9.6.6.1 Company overview
9.6.6.2 Financial performance
9.6.6.3 Product benchmarking
9.6.6.4 Strategic Initiatives
9.6.7 F. Hoffmann-La Roche Ltd.
9.6.7.1 Company overview
9.6.7.2 Financial performance
9.6.7.3 Product benchmarking
9.6.7.4 Strategic initiatives
9.6.8 Hitachi, Ltd
9.6.8.1 Company overview
9.6.8.2 Financial performance
9.6.8.3 Product benchmarking
9.6.8.4 Strategic initiatives
9.6.9 Koninklijke Philips N.V.
9.6.9.1 Company overview
9.6.9.2 Financial performance
9.6.9.3 Product benchmarking
9.6.9.4 Strategic initiatives
9.6.10 Abbott
9.6.10.1 Company overview
9.6.10.2 Financial performance
9.6.10.3 Product benchmarking
9.6.10.4 Strategic initiatives
9.6.11 Danaher
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.11.4 Strategic initiatives
9.6.12 Prestige Biopharma Ltd.
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.11.4 Strategic initiatives
9.6.13 BioMarker Strategies
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.11.4 Strategic initiatives
9.6.14 ASURAGEN, INC
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.11.4 Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 Global Pancreatic Cancer Diagnostic Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 6 Global Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 7 Global Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 8 Global Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 9 North America Pancreatic Cancer Diagnostic Market, By Country, 2018 - 2030 (USD Million)
Table 10 North America Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 11 North America Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 12 North America Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 13 North America Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 14 U.S. Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 15 U.S. Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 16 U.S. Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 17 U.S. Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 18 Canada Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 19 Canada Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 20 Canada Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 21 Canada Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 22 Europe Pancreatic Cancer Diagnostic Market, By Country, 2018 - 2030 (USD Million)
Table 23 Europe Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 24 Europe Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 25 Europe Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 26 Europe Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 27 UK Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 28 UK Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 29 UK Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 30 UK Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 31 Germany Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 32 Germany Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 33 Germany Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 34 Germany Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 35 France Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 36 France Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 37 France Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 38 France Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 39 Italy Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 40 Italy Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 41 Italy Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 42 Italy Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 43 Spain Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 44 Spain Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 45 Spain Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 46 Spain Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 47 Denmark Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 48 Denmark Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 49 Denmark Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 50 Denmark Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 51 Norway Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 52 Norway Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 53 Norway Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 54 Norway Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 55 Sweden Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 56 Sweden Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 57 Sweden Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 58 Sweden Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Pancreatic Cancer Diagnostic Market, By Country, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 63 Asia Pacific Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 64 Japan Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 65 Japan Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 66 Japan Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 67 Japan Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 68 China Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 69 China Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 70 China Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 71 China Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 72 India Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 73 India Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 74 India Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 75 India Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 76 South Korea Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 77 South Korea Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 78 South Korea Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 79 South Korea Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 80 Australia Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 81 Australia Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 82 Australia Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 83 Australia Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 84 Thailand Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 85 Thailand Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 86 Thailand Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 87 Thailand Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 88 Latin America Pancreatic Cancer Diagnostic Market, By Country, 2018 - 2030 (USD Million)
Table 89 Latin America Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 90 Latin America Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 91 Latin America Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 92 Latin America Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 93 Brazil Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 94 Brazil Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 95 Brazil Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 96 Brazil Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 97 Argentina Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 98 Argentina Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 99 Argentina Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 100 Argentina Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 101 Mexico Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 102 Mexico Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 103 Mexico Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 104 Mexico Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 105 Middle East and Africa Pancreatic Cancer Diagnostic Market, By Country, 2018 - 2030 (USD Million)
Table 106 Middle East and Africa Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 107 Middle East and Africa Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 108 Middle East and Africa Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 109 Middle East and Africa Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 110 South Africa Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 111 South Africa Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 112 South Africa Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 113 South Africa Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 117 Saudi Arabia Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 118 UAE Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 119 UAE Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 120 UAE Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 121 UAE Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 122 Kuwait Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 123 Kuwait Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 124 Kuwait Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 125 Kuwait Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 Global Pancreatic Cancer Diagnostic Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 6 Global Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 7 Global Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 8 Global Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 9 North America Pancreatic Cancer Diagnostic Market, By Country, 2018 - 2030 (USD Million)
Table 10 North America Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 11 North America Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 12 North America Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 13 North America Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 14 U.S. Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 15 U.S. Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 16 U.S. Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 17 U.S. Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 18 Canada Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 19 Canada Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 20 Canada Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 21 Canada Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 22 Europe Pancreatic Cancer Diagnostic Market, By Country, 2018 - 2030 (USD Million)
Table 23 Europe Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 24 Europe Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 25 Europe Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 26 Europe Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 27 UK Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 28 UK Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 29 UK Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 30 UK Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 31 Germany Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 32 Germany Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 33 Germany Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 34 Germany Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 35 France Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 36 France Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 37 France Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 38 France Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 39 Italy Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 40 Italy Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 41 Italy Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 42 Italy Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 43 Spain Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 44 Spain Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 45 Spain Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 46 Spain Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 47 Denmark Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 48 Denmark Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 49 Denmark Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 50 Denmark Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 51 Norway Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 52 Norway Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 53 Norway Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 54 Norway Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 55 Sweden Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 56 Sweden Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 57 Sweden Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 58 Sweden Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Pancreatic Cancer Diagnostic Market, By Country, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 63 Asia Pacific Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 64 Japan Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 65 Japan Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 66 Japan Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 67 Japan Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 68 China Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 69 China Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 70 China Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 71 China Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 72 India Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 73 India Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 74 India Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 75 India Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 76 South Korea Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 77 South Korea Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 78 South Korea Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 79 South Korea Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 80 Australia Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 81 Australia Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 82 Australia Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 83 Australia Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 84 Thailand Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 85 Thailand Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 86 Thailand Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 87 Thailand Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 88 Latin America Pancreatic Cancer Diagnostic Market, By Country, 2018 - 2030 (USD Million)
Table 89 Latin America Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 90 Latin America Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 91 Latin America Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 92 Latin America Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 93 Brazil Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 94 Brazil Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 95 Brazil Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 96 Brazil Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 97 Argentina Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 98 Argentina Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 99 Argentina Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 100 Argentina Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 101 Mexico Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 102 Mexico Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 103 Mexico Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 104 Mexico Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 105 Middle East and Africa Pancreatic Cancer Diagnostic Market, By Country, 2018 - 2030 (USD Million)
Table 106 Middle East and Africa Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 107 Middle East and Africa Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 108 Middle East and Africa Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 109 Middle East and Africa Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 110 South Africa Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 111 South Africa Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 112 South Africa Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 113 South Africa Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 117 Saudi Arabia Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 118 UAE Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 119 UAE Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 120 UAE Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 121 UAE Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
Table 122 Kuwait Pancreatic Cancer Diagnostic Market, By Product, 2018 - 2030 (USD Million)
Table 123 Kuwait Pancreatic Cancer Diagnostic Market, By Test Type, 2018 - 2030 (USD Million)
Table 124 Kuwait Pancreatic Cancer Diagnostic Market, By Cancer Type, 2018 - 2030 (USD Million)
Table 125 Kuwait Pancreatic Cancer Diagnostic Market, By End-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Pancreatic cancer diagnostic market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2022)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Porter’s five forces analysis
Fig. 14 PESTLE analysis
Fig. 15 Pancreatic cancer diagnostic market: Product movement analysis
Fig. 16 Pancreatic cancer diagnostic market: Product segment dashboard
Fig. 17 Pancreatic cancer diagnostic market Product outlook: Key takeaways
Fig. 18 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Pancreatic cancer diagnostic market: Test type movement analysis
Fig. 22 Pancreatic cancer diagnostic market: Test type segment dashboard
Fig. 23 Pancreatic cancer diagnostic market Test type outlook: Key takeaways
Fig. 24 Imaging test market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 CT scan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 MRI market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Ultrasound market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 PET market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Biopsy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Blood test market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Liver function test market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Tumor markers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Other blood tests market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Pancreatic cancer diagnostic market: Cancer type movement analysis
Fig. 37 Pancreatic cancer diagnostic market: Cancer type segment dashboard
Fig. 38 Pancreatic cancer diagnostic market Cancer type outlook: Key takeaways
Fig. 39 Exocrine cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Adenocarcinoma market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Squamous cell carcinoma market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Adenosquamous carcinoma market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Colloid carcinoma market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Endocrine cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Pancreatic cancer diagnostic market: End-use movement analysis
Fig. 46 Pancreatic cancer diagnostic market: End-use segment dashboard
Fig. 47 Pancreatic cancer diagnostic market End-use outlook: Key takeaways
Fig. 48 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Regional outlook, 2022 & 2030
Fig. 53 Regional market dashboard
Fig. 54 Regional market place: Key takeaways
Fig. 55 North America, SWOT
Fig. 56 Europe, SWOT
Fig. 57 Asia Pacific, SWOT
Fig. 58 Latin America, SWOT
Fig. 59 Middle East and Africa, SWOT
Fig. 60 North America
Fig. 61 North America pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 62 U.S.
Fig. 63 U.S. pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 64 Canada
Fig. 65 Canada pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 66 Europe
Fig. 67 Europe pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 68 UK
Fig. 69 UK pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 70 Germany
Fig. 71 Germany pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 72 Spain
Fig. 73 Spain pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 74 France
Fig. 75 France pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 76 Italy
Fig. 77 Italy pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 78 Denmark
Fig. 79 Denmark pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 80 Norway
Fig. 81 Norway pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 82 Sweden
Fig. 83 Sweden pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 84 Asia Pacific
Fig. 85 Asia Pacific pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 86 Japan
Fig. 87 Japan pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 88 China
Fig. 89 China pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 90 India
Fig. 91 India pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 92 South Korea
Fig. 93 South Korea pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 94 Australia
Fig. 95 Australia pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 96 Thailand
Fig. 97 Thailand pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 98 Latin America
Fig. 99 Latin America pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 100 Brazil
Fig. 101 Brazil pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 102 Mexico
Fig. 103 Mexico pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 104 Argentina
Fig. 105 Argentina pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 106 Middle East and Africa
Fig. 107 MEA pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 108 South Africa
Fig. 109 South Africa pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 110 Saudi Arabia
Fig. 111 Saudi Arabia pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 112 UAE
Fig. 113 UAE pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 114 Kuwait
Fig. 115 Kuwait pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 116 Ansoff Matrix
Fig. 117 Heat map analysis
Fig. 118 Market differentiators
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2022)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Porter’s five forces analysis
Fig. 14 PESTLE analysis
Fig. 15 Pancreatic cancer diagnostic market: Product movement analysis
Fig. 16 Pancreatic cancer diagnostic market: Product segment dashboard
Fig. 17 Pancreatic cancer diagnostic market Product outlook: Key takeaways
Fig. 18 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Pancreatic cancer diagnostic market: Test type movement analysis
Fig. 22 Pancreatic cancer diagnostic market: Test type segment dashboard
Fig. 23 Pancreatic cancer diagnostic market Test type outlook: Key takeaways
Fig. 24 Imaging test market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 CT scan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 MRI market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Ultrasound market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 PET market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Biopsy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Blood test market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Liver function test market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Tumor markers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Other blood tests market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Pancreatic cancer diagnostic market: Cancer type movement analysis
Fig. 37 Pancreatic cancer diagnostic market: Cancer type segment dashboard
Fig. 38 Pancreatic cancer diagnostic market Cancer type outlook: Key takeaways
Fig. 39 Exocrine cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Adenocarcinoma market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Squamous cell carcinoma market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Adenosquamous carcinoma market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Colloid carcinoma market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Endocrine cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Pancreatic cancer diagnostic market: End-use movement analysis
Fig. 46 Pancreatic cancer diagnostic market: End-use segment dashboard
Fig. 47 Pancreatic cancer diagnostic market End-use outlook: Key takeaways
Fig. 48 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Regional outlook, 2022 & 2030
Fig. 53 Regional market dashboard
Fig. 54 Regional market place: Key takeaways
Fig. 55 North America, SWOT
Fig. 56 Europe, SWOT
Fig. 57 Asia Pacific, SWOT
Fig. 58 Latin America, SWOT
Fig. 59 Middle East and Africa, SWOT
Fig. 60 North America
Fig. 61 North America pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 62 U.S.
Fig. 63 U.S. pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 64 Canada
Fig. 65 Canada pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 66 Europe
Fig. 67 Europe pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 68 UK
Fig. 69 UK pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 70 Germany
Fig. 71 Germany pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 72 Spain
Fig. 73 Spain pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 74 France
Fig. 75 France pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 76 Italy
Fig. 77 Italy pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 78 Denmark
Fig. 79 Denmark pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 80 Norway
Fig. 81 Norway pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 82 Sweden
Fig. 83 Sweden pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 84 Asia Pacific
Fig. 85 Asia Pacific pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 86 Japan
Fig. 87 Japan pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 88 China
Fig. 89 China pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 90 India
Fig. 91 India pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 92 South Korea
Fig. 93 South Korea pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 94 Australia
Fig. 95 Australia pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 96 Thailand
Fig. 97 Thailand pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 98 Latin America
Fig. 99 Latin America pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 100 Brazil
Fig. 101 Brazil pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 102 Mexico
Fig. 103 Mexico pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 104 Argentina
Fig. 105 Argentina pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 106 Middle East and Africa
Fig. 107 MEA pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 108 South Africa
Fig. 109 South Africa pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 110 Saudi Arabia
Fig. 111 Saudi Arabia pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 112 UAE
Fig. 113 UAE pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 114 Kuwait
Fig. 115 Kuwait pancreatic cancer diagnostic market, 2018 - 2030 (USD Million)
Fig. 116 Ansoff Matrix
Fig. 117 Heat map analysis
Fig. 118 Market differentiators
Companies Mentioned
- QIAGEN
- Illumina, Inc.
- BD
- Thermo Fisher Scientific, Inc.
- Myriad Genetics, Inc.
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Hitachi, Ltd
- Koninklijke Philips N.V.
- Abbott
- Danaher
- Prestige Biopharma Ltd.
- BioMarker Strategies
- ASURAGEN, INC
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | May 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 2.37 Billion |
| Forecasted Market Value ( USD | $ 3.9 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
